SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-019878
Filing Date
2024-05-15
Accepted
2024-05-15 16:16:24
Documents
90
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1386141
2 ex10-1.htm EX-10.1 30928
3 ex10-2.htm EX-10.2 92601
4 ex10-3.htm EX-10.3 98557
5 ex31-1.htm EX-31.1 11975
6 ex31-2.htm EX-31.2 12104
7 ex32-1.htm EX-32.1 7606
8 ex32-2.htm EX-32.2 7651
9 ex10-2_001.jpg GRAPHIC 2043
10 ex10-3_001.jpg GRAPHIC 2496
  Complete submission text file 0001493152-24-019878.txt   7096190

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE bfri-20240331.xsd EX-101.SCH 55055
12 XBRL CALCULATION FILE bfri-20240331_cal.xml EX-101.CAL 73324
13 XBRL DEFINITION FILE bfri-20240331_def.xml EX-101.DEF 272246
14 XBRL LABEL FILE bfri-20240331_lab.xml EX-101.LAB 398412
15 XBRL PRESENTATION FILE bfri-20240331_pre.xml EX-101.PRE 342901
94 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1019670
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Filer) CIK: 0001858685 (see all company filings)

IRS No.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40943 | Film No.: 24951027
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)